Nadami MIMURA and Yui TAMURA
Showa University Graduate School of Health Sciences, Japan
Scientific Tracks Abstracts: J Nephrol Ther
Purpose : This study aims to search the decision-making of EOL with one peritoneal dialysis patient (Mr. A) family at home. We classify reasons that family members were able to care for the patient until the EOL at home. Method : We interviewed Mr. A’s daughter after he had died. An interviewer asked about the trajectory of End of Life (EOL) from PD beginning to the patient’s death. We used recording data and qualitative analysis by storyline to look for the feelings of a patient’s family. Result : The patient was Mr. A: a male and was 98 years old at the time of death. From the age of 96 to 98, he was treated with peritoneal dialysis at home. The daughter was the primary caregiver and lived with the patient while working at the family wholesale business. The patient’s wife died several years ago. The daughter expressed 6 sections of spending their trajectory, and also, felt anxiety and confidence that she would be caring for her father. The 6 sections are “Starting PD”, “Admission to a hospital”, “Came back to home”, “Changing daily life”, “Poor appetite”, and “Last movement”. Discussion : They made decisions during all sections of traction. This decision-making had a lot of causes for concern, but also, they tried home-setting treatment. The daughter loved her father and said her priority was that it was good for her father. In addition, the important support for her was that all medical and helpers knew her efforts. Conclusion : Professionals need to support caregivers throughout their daily lives.
Nadami MIMURA has completed her Doctor of Nursing Sciences from Tokyo Medical Dental University. She is a professor of Nursing sciences at Showa University, her work focuses specifically on the End-of-life of dialysis patients setting home. She has published about 100 papers with supported grants (JSPS KAKENHI Grant Number JP22592620, JP15K11819, and JP19K11205.)
Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report